BIOMAT Database Logo BIOMAT Database Logo

The prothrombin time and monitoring oral anticoagulant therapy. 1986

A Brownell, and I J Mackie, and S J Machin

UI MeSH Term Description Entries
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

A Brownell, and I J Mackie, and S J Machin
Monitoring oral anticoagulant therapy--INR values for the Owren prothrombin time.
February 2004, Thrombosis and haemostasis,
A Brownell, and I J Mackie, and S J Machin
Comparison of the native prothrombin antigen and the prothrombin time for monitoring oral anticoagulant therapy.
August 1984, Blood,
A Brownell, and I J Mackie, and S J Machin
A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy.
January 2003, Pathophysiology of haemostasis and thrombosis,
A Brownell, and I J Mackie, and S J Machin
Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy.
January 2009, Clinical chemistry and laboratory medicine,
A Brownell, and I J Mackie, and S J Machin
Randomized prospective trial comparing the native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant therapy.
January 1990, Blood,
A Brownell, and I J Mackie, and S J Machin
Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy?
March 2005, Clinical chemistry,
A Brownell, and I J Mackie, and S J Machin
Cost-minimisation analysis of oral anticoagulant therapy monitoring methods: the case for prothrombin time self-monitoring.
January 2008, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese,
A Brownell, and I J Mackie, and S J Machin
Comparison of native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant prophylaxis.
August 1993, Circulation,
A Brownell, and I J Mackie, and S J Machin
Monitoring oral anticoagulant therapy by the prothrombin time: reporting the coagulation activity or the international normalized ratio?
January 1994, Haemostasis,
A Brownell, and I J Mackie, and S J Machin
Standardization of prothrombin time for laboratory control of oral anticoagulant therapy.
January 1999, Seminars in thrombosis and hemostasis,
Copied contents to your clipboard!